Unlike some simplistic anti-cancer methods, ANG4’s inhibitory action does not rely on a direct toxic attack on tumor cells, but rather takes a smarter path - hitting the lifeblood of angiogenesis head-on. The gene discussed is ANGPT4; the disease is neoplasm.